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The sarco(endo)plasmic reticulum Ca2+-ATPase mRNA isoform, SERCA 3, was previously shown to be expressed in a great variety of muscle 
and non-muscle tissues [(1989) J. Biol. Chem. 264, 18561-18568] but its cellular localization within these organs was unknown. We have used in 
situ hybridization and RNase protection techniques to demonstrate hat SERCA 3 mRNA is expressed in specific ell types, namely the endothelial 
and epithelial cells. 
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1. INTRODUCTION 
The sarco(endo)reticulum (SR/ER) Ca2+-ATPase is 
involved in the transport of Ca 2+ from the cytosol to 
various intracellular Ca 2+ stores, such as the sarcoplas- 
mic reticulum, the endoplasmic reticulum and the calci- 
osomes. It is present in several cell types and plays an 
important role in controlling cellular functions, such as 
relaxation and secretion. Multiple CaZ+-ATPase 
isoforms have been identified by cDNA cloning. They 
are encoded by three different genes (SERCA 1, 2 and 
3) and result from alternative splicing of pre-mRNA 
transcripts [1-3]. The SERCA 1 gene is exclusively ex- 
pressed in fast skeletal muscle [4,5]. The SERCA 2 gene 
gives rise to two alternatively spliced transcripts, one of 
which, SERCA 2a, has been detected in adult cardiac 
muscle, in slow skeletal muscle and in some smooth 
muscle tissues whereas the other, SERCA 2b, is found 
in adult smooth muscle and in non-muscle tissues [6- 
12]. SERCA 3, originally isolated from adult rat kidney, 
is highly homologous to SERCA 1 and SERCA 2 
mRNAs; it was shown to be expressed in a broad vari- 
ety of muscle and non-muscle tissues [1] but its cellular 
localization remained unknown. We have used in situ 
mRNA hybridization and RNase protection assays to 
demonstrate that, in several organs, SERCA 3 is ex- 
pressed in specific ell types, namely the arterial endo- 
thelial cells and some epithelial cells. 
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2. MATERIALS AND METHODS 
2.1. Complementary DNA probes 
SERCA 3 and SERCA 2b cDNA probes were prepared by PCR 
amplification. They correspond to nucleotides 1,107 1,523 and 3,489 
3,630 of the sequences published by Burk et al. [1] and Gunteski- 
Hamblin et al. [7], respectively. For SERCA 3, first-strand cDNA was 
synthesized from t ,ug of poly(A) + RNA isolated from spleen using 
oligo(dT) primer and Moloney murine leukemia virus reverse tran- 
scriptase (Gibco BRL Life Technologies) at 37°C. For SERCA 2b, 10 
,ug of total RNA from rat aortic smooth muscle cells in subculture 
were transcribed at 42°C using avian myeloblastosis virus reverse 
transcriptase (Boehringer-Mannheim) and the 3'-end primer. DNA 
amplification was performed in the presence of Taq polymerase (2.5 
U) and the PCR conditions for amplification of SERCA 3 mRNA 
were 1 min at 94°C, 2 rain at 45°C, 1 rain at 72°C followed by 40 cycles 
of 1 min at 94°C, 1 min at 55°C and 1 min at 72°C. The amplified 
SERCA 3 fragment was blunt-end ligated to the Sinai site of pGEM- 
7ZF(+) vector. After an initial incubation of 2 min at 92°C, SERCA 
2b mRNA was amplified by 30 cycles of 1 rain at 92°C, 2 rain at 55°C 
and 3 min at 72°C. HindlII and Xhol restriction sites were included 
in the primers and the amplified fragment was inserted in the corre- 
sponding sites of the pB II KS vector (Stratagene). Double-stranded 
DNA was sequenced using the Sequenase kit (USB) to confirm the 
amplification of the expected product. The s-smooth muscle actin 
probe was a gift from Dr. Gabbiani (Geneva), a 130 nucleotide Ddel 
HindIII DNA fragment corresponding toa part of the 3' untranslated 
region of the s-smooth muscle (~-Sm) actin mRNA that was sub- 
cloned in the pSP64 vector. Its specificity had been determined previ- 
ously [13]. 
2.2. cRNA probes 
Complementary RNA probes were transcribed in vitro from 
HindIII-linearized plasmids in the presence of T 7 (SERCA 3) or T 3 
(SERCA 2b) RNA polymerases (Promega) or from EcoRI-linearized 
plasmid and SP 6 RNA polymerase (c~-Sm). [35S]UPT (1,000 Ci/mmol; 
Amersham) was used as the labeled nucleotide triphosphate. Unincor- 
porated nucleotides were removed by two ethanol precipitations. All 
probes were diluted to a final specific activity of about 60,000 cpm/,ul 
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in 50% formamide, 0.3 M NaC1, 20 mM Tris-HC1 (pH 8.0), 5 mM 
EDTA, 10 mM sodium phosphate (pH 8.0), 10% dextran sulfate, 1 x 
Denhardt's, 0.5 mg/ml yeast RNA and 20 mM dithiothreitol (DTT). 
Labeled sense sequences synthesized n vitro from the same plasmids 
were used to test the specificity of the respective probes. 
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2.3. RNase protection analysis 
Tissues from adult Wistar rats were xcised and quickly frozen in 
liquid nitrogen. Rat aortic endothelial cells and rat aortic smooth 
muscle cells were collected after two and four passages, respectively. 
The cells were collected by centrifugation and the pellets frozen in 
liquid nitrogen. Total RNA was extracted by the guanidinium isothio- 
cyanate procedure [14]. 10 ,ug of total RNA were used for RNase 
protection analysis, cRNA probes were labeled as described above 
using [~-32p]CTP (1,000 Ci/mmol; Amersham) as the labeled nucleo- 
tide triphosphate. The full-length fragments, purified on acrylamide- 
urea denaturing els, were hybridized to total RNA in 80% formamide 
at 42°C overnight. After hybridization, the unreacted cRNA probes 
were digested in the presence of 0.5/.tg of RNase A and 10 U of RNase 
T1 at 37°C for 30 min following the RPA II protocol (Ambion; 
Clinisciences; France). Each experiment included a control reaction 
in which total RNA was replaced by 10 fig of yeast tRNA. After 
digestion, the protected probes were separated by electrophoresis on
6% polyacrylamide gels. The gels were dried and exposed to X-ray 
films (Kodak; France). 
2.4. In situ hybridization 
The tissues were fixed in 2% paraformaldehyde in PBS (phosphate- 
buffered saline) for 2 h at 4°C, then washed in PBS containing 30% 
sucrose for 4 h at 4°C, embedded in OCT (RUA; Torcy; France), and 
frozen in liquid nitrogen-cooled isopentane. Serial cryosections (5-tim 
thick) were transferred to chromium alum gelatin-coated sli es, dried 
a few minutes at room temperature, fixed in 4% paraformaldehyde for 
5 min, washed in PBS (2 x 5 min), then dehydrated in ethanol and 
stored at -70°C with dessicant until use. 
In situ hybridization procedures w re similar to those described by 
Wilkinson et al. [15]. About 7 ,ul of hybridization mixture containing 
the cRNA probe (400,000 cpm) were applied to each section. The 
slides were incubated at 50°C overnight. After one washing at 50°C 
in 5 x SSC (1 x SSC = 0.15 M sodium chloride and 0.015 M sodium 
citrate) and 10 mM DTT, the slides were incubated in 50% formamide, 
2 x SSC and 0.1 M DTT at 65°C for 20 min, treated with 20/lg/ml 
RNase A at 37°C for 30 min, and washed twice in 2 x SSC and twice 
in 0.l x SSC at room temperature. After dehydration, the slides were 
immersed in Kodak NTB2 Nuclear track emulsion (Eastman Kodak) 
drained of excess fluid and autoradiographed. After 15 days, sections 
were developed in Kodak D19, mounted, and examined by light- and 
dark-field illumination. 
3. RESULTS AND DISCUSSION 
The expression of the SERCA 3 mRNA isoform in 
different organs was determined by RNase protection 
analysis (Fig. 1). SERCA 3 mRNA was highly ex- 
pressed in the trachea, was present at lower level in the 
liver and the aorta, but was undetectable in either the 
lung or the heart. The results confirm that SERCA 3 is 
expressed in several muscular and non-muscular organs 
as already reported by Burk et al. [1] using Northern 
blot analysis. Some discrepancies in the level of expres- 
sion of SERCA 3 in the various organs were observed 
between both sets of data. Due to the cell-specific ex- 
pression of SERCA 3 in these organs (see below), heter- 
ogeneity in the sample used to prepare the RNA may 
well explain these differences. Alternatively, some cross- 
Fig. 1. RNase protection analysis of total RNA from heart, liver, lung, 
trachea nd aorta of adult rat hybridized with the SERCA 3 probe. 
10pg of total RNA from various tissues and 10fig of yeast RNA were 
hybridized with the radiolabeled SERCA 3 cRNA probe. After ribo- 
nuclease digestion, the protected fragments were separated on 6% 
sequencing gel. 'Probe' indicates the position of the undigested probe. 
The position of the partially protected fragment is indicated by an 
arrow; it was smaller than the undigested probe since the probe con- 
tained plasmid sequences which did not hybridize to mammalian 
RNA. Furthermore control hybridization and digestion in the pres- 
ence of tRNA alone clearly indicated the specificity of the probe and 
the complete RNAse digestion of single-stranded cRNA. The gels 
were exposed to X-ray films for 4 days. 
hybridization of the SERCA 3 probe with other 
SERCA mRNA species in the Northern hybridization 
may also lead to over-estimation f SERCA 3 expres- 
sion. 
To determine precisely the cellular specificity of ex- 
pression of SERCA 3 in these organs, SERCA 3 mRNA 
was labeled in situ with a specific RNA probe. Sections 
from aortic trunk (Fig. 2AC) ,  myocardium (Fig. 2D- 
F), trachea (Fig. 2G,H) and liver (Fig. 2I,J) were labeled 
with the SERCA 3 probe (Fig. 2A,D,G,I) and the c¢-Sm 
actin probe (B,E). The ~-Sm actin probe was used as a 
marker of the smooth muscle cells to delineate the me- 
dial layer in the vessels. The structures were also visual- 
ized in bright-field (Fig. 2C,F,H,I). On sections from 
either the aortic trunk (Fig. 2A,C), or the myocardium 
(Fig. 2D,F) SERCA 3 mRNA was detected only in the 
luminal part of the arterial wall, whereas the ~-Sm actin 
probe clearly hybridized with the medial ayer. A strong 
accumulation of SERCA 3 mRNA transcripts is ob- 
served in the layers bordering the lumen of the trachea 
corresponding to epithelial cells (Fig. 2G,H). In adult 
liver, SERCA 3 mRNA was detected only at the luminal 
side of the arterial wall (Fig. 2I,J). The specific expres- 
sion of SERCA 3 in heart, aorta, liver and trachea 
demonstrated by in situ hybridization is in agreement 
with the levels of mRNA detected by RNase protection 
assay. In order to further confirm the expression of 
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Fig. 2. Localization of SERCA 3 and ~-Sm actin mRNAs in different rat tissues. Vascular trunk (A,C), coronary arteries (D,F), trachea (G,H) 
and adult liver (I,J), hybridized with SERCA 3 (A,D,G,I) and ~-Sm actin (B,E) cRNA probes or visualized with bright-field (C,F,H,J). SERCA 
3 mRNA was detected in endothelial cells and in epithelial cells (arrow). The c~-Sm actin was detected in the medial layer of the vessels. Bar = (A,C) 
100 tim; (D,F) 60 tim; (G,H) 50 tim; (I,J) 60 tim. Only background signal was observed with the sense probes. 
SERCA 3 in endothelial cells, we performed RNase 
protection analysis using RNA from isolated aortic en- 
dothelial cells in culture. SERCA 3 mRNA was present 
in subcultured aortic endothelial cells but not in aortic 
smooth muscle cells (Fig. 3), whereas SERCA 2b was 
present in both cell types. Based on the in situ localiza- 
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system for arterial endothel ium, but the mechanism of  
activation of  Ca z+ entry and Ca 2+ release remains to be 
established. The low affinity for Ca 2+ of  SERCA 3 com- 
pared to all the other SERCA isoforms [19,20] suggests 
a part icular mechanism of  activation. 
Our results demonstrate for the first time that, in the 
adult  rat, SERCA 3 is expressed in a great variety of  
organs but that its expression is restricted to a subset of  
cells, namely the arterial endothel ial  cells. In the tra- 
chea, its expression is restricted to the epithelial cells. 
SERCA 2b SERCA 3 
Fig. 3. RNase protection analysis of RNA from subcultured endothe- 
lial cells (EC) and subcultured aortic smooth muscle cells (SMC). 5 ~g 
of total RNA hybridized with SERCA 3 and SERCA 2b cRNA 
probes. 'Probe' indicates the position of the undigested probe. The 
position of the partially protected fragments is indicated by arrows. 
tion of  these cells in a thin layer bordering the lumen of  
the vessels and on the fact that SERCA 3 mRNA is 
observed in isolated arterial endothel ial  cells in culture, 
we conclude that the arterial endothel ial  cells express 
the SERCA 3 gene. We had previously demonstrated 
the presence of  SR/ER CaZ+-ATPase in human omental  
microvascular endothel ial  cells [16], and the present 
study indicates that the SERCA 3 isoform is a major  
SR/ER Ca2+-ATPase xpressed in vivo in arterial endo- 
thelial cells. The presence of  a large amount  of  an or- 
ganellar type of  Ca2+-ATPase mRNA in endothel ial  
cells is not surprising since ER is abundant  in this cell 
type and the intracel lular Ca 2+compartment  is of  major  
importance in control l ing the release of  paracrine fac- 
tors responsible for the regulation of  the vascular tone 
[17]. As shown by both RNase protect ion analysis and 
in situ hybridizat ion, SERCA 3 mRNA is also abun- 
dant in the tracheal epithelium. In this cell type, SERCA 
3 might be important  in control l ing secretion. The pro- 
tein composit ion of  the ER in endothel ial  and epithelial 
cells has not been well characterized. In addit ion to the 
presence of  SERCA 3 which we now report, Lesh et al. 
[18] have demonstrated the presence of  ryanodine recep- 
tors, the CaZ+-induced Ca 2+ release channels, through- 
out the ER of  arterial endothel ium. It remains to be 
determined which ryanodine receptor isoform is ex- 
pressed in endothel ial  cells and whether SERCA 3 and 
the ryanodine receptor are present in the same subcellu- 
lar structure. The presence of  both ryanodine receptors 
and SERCA 3 would constitute a unique Ca 2+ transport  
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